Biotech Stocks To Consider – January 12th
by Teresa Graham · The Cerbat GemCidara Therapeutics, Abivax, and Danaher are the three Biotech stocks to watch today, according to MarketBeat’s stock screener tool. Biotech stocks are shares of publicly traded companies that research, develop, and commercialize biological therapies, diagnostics, and related life‑science technologies. For investors they tend to be high‑volatility, high‑reward assets whose value is driven largely by clinical trial results, regulatory approvals, patent news, and partnership or licensing deals. These companies had the highest dollar trading volume of any Biotech stocks within the last several days.
Cidara Therapeutics (CDTX)
Cidara Therapeutics, Inc., a biotechnology company, focuses on developing targeted therapies for patients facing cancers and other serious diseases. The company's product includes rezafungin acetate, a novel molecule in the echinocandin class of antifungals for the treatment and prevention of invasive fungal infections, including candidemia and invasive candidiasis, which are fungal infections associated with high mortality rates.
Read Our Latest Research Report on CDTX
Abivax (ABVX)
ABIVAX Société Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics that harness the body's natural regulatory mechanisms to stablize the immune response in patients with chronic inflammatory diseases. The company is evaluating its lead drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of moderately to severely active ulcerative colitis in adults.
Read Our Latest Research Report on ABVX
Danaher (DHR)
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Read Our Latest Research Report on DHR
Featured Stories
- MarketBeat’s Top Five Stocks to Own in January 2026
- The Next Market Leaders? 5 Growth Stocks to Watch in 2026
- Power Hungry: Inside Meta’s Huge Investment in a Nuclear Strategy
- WD-40 Stock Sank After Earnings—Here Are 5 Reasons Bulls Aren’t Worried
- 3 Oversold Stocks Ready to Rebound in 2026
- Is Netflix a Buy Ahead of Earnings? It Looks Like It